SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001564590-19-008313
Filing Date
2019-03-18
Accepted
2019-03-18 16:52:17
Documents
3
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A sndx-10ka_20181231.htm 10-K/A 173339
2 EX-31.1 sndx-ex311_6.htm EX-31.1 7191
3 EX-31.2 sndx-ex312_7.htm EX-31.2 7210
  Complete submission text file 0001564590-19-008313.txt   188781
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37708 | Film No.: 19688868
SIC: 2834 Pharmaceutical Preparations